Serum OPG analysis in > 6000 healthy subjects (Vik et al., 2015) showed an inverse relation in younger women (< 60 years) between serum OPG and risk of incident cancer at all sites, but primarily in the breast and reproductive tract (Vik et al., 2015). This evidence concerns the gene TNFRSF11B and cancer.